CClinicalTrials.gg
WithdrawnNCT01446588OHAYSUpdated May 26, 2014

Ocular Hypertension And Yoga Study

An interventional study of Yoga Intervention in Ocular Hypertension, Sleep Disturbance and Stress, sponsored by Johns Hopkins University. Withdrawn at 1 site in United States. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-05-26.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Treatment

Why this study was withdrawn
No Funding was acquired.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
18 Years to 90 Years
Sex
All
01

Study summary

The investigators aim to pilot test the efficacy of a yoga intervention designed specifically for individuals with ocular hypertension. The investigators would like to find out if a combination of breathing, postures and meditation may help to reduce intraocular pressure in the short term after each yoga session, and also long-term across an 8-week program. Subjects will participate in the yoga intervention sessions led by Dr. Pamela Jeter once a week at the investigators center, and will be asked to practice at home at least twice a week using a audio CD.

02

Conditions studied

  • Ocular Hypertension
  • Sleep Disturbance
  • Stress
  • Anxiety
  • Depression
03

In context

Ocular Hypertension

649 studies on the registry are indexed under Ocular Hypertension; 48 are open to participants now.

Browse Ocular Hypertension studies →

Lead sponsor

Johns Hopkins University is the lead sponsor of 1,783 studies on the registry; 313 are open to participants now.

Of its 203 completed or terminated interventional studies of FDA-regulated products, 140 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age 18+
  • Diagnosis of ocular hypertension not requiring treatment of IOP
  • IOP in at least one eye ≥ 21 mm Hg
  • Normal Humphrey 24-2 or 30-2 visual fields for both eyes as determined by the patient's glaucoma specialist
  • Best-corrected visual acuity better than 20/40 in both eyes
  • Being healthy to the extent that participation in yoga therapy would not exacerbate any existing disease conditions;
  • Participants do not engage in athletic activity on a regular basis (i.e. are sedentary)
  • Able and willing to participate on a weekly basis for the 11-week intervention;
  • Informed consent

Exclusion criteria

Exclusion Criteria:

VISUAL HISTORY

  • Any visual field loss in either eye consistently detected with Humphrey Visual Field 30-2 or 24-2
  • Inability to understand study procedures or communicate responses to visual stimuli in a consistent manner (cognitive impairment)
  • Previous intraocular surgery, except for uncomplicated extracapsular cataract extraction with posterior chamber-intraocular lens implant and no escape of vitreous to the anterior chamber, strabismus, cosmetic eyelid surgery, and radial keratotomy
  • Secondary causes of elevated IOP, including ocular and systemic corticosteroid use
  • Angle closure glaucoma or anatomically narrow angles-75% of the circumference of the angle must be grade 2 or more by Shaffer criteria
  • Pigmentary glaucoma
  • Congenital glaucoma
  • Other diseases that cause visual field loss or optic disc abnormalities
  • Difference in cup-disc ratios (horizontal by contour) between the two eyes of >0.2
  • Background diabetic retinopathy, defined as at least 1 microaneurysm seen on ophthalmoscopy with dilated pupil, or any retinal hemorrhage

SPECIFIC SYSTEMIC DISEASES/CONDITIONS

  • Abdominal Aneurism
  • Cancer, metastatic
  • Fibromyalgia, severe
  • Inflammatory autoimmune diseases (e.g. Lupus, Rheumatoid arthritis, Scleroderma)
  • Other disabling chronic conditions (e.g., disabling heart or lung disease, diabetic neuropathy, receiving treatment for hepatitis)
  • A life-threatening or debilitating disease

BACK PROBLEM OF COMPLICATED NATURE, INCLUDING MEDICO-LEGAL ISSUES

  • Seeking/receiving compensation/litigation for back pain
  • Previous back surgery, ever
  • Low back pain that has lasted > 1 month
  • Severe pain when bending or twisting spine
  • Sciatica
  • Discitis or Disk disease
  • Fracture of vertebra
  • Infectious cause of back pain
  • Scoliosis, severe or progressive
  • Spinal stenosis
  • Spondylolisthesis
  • Anklyosing spondylitis

CONDITIONS THAT MIGHT MAKE IT DIFFICULT TO ATTEND THE CLASSES OR PRACTICE AT HOME.

  • Deafness or severe hearing problems
  • Psychoses, major
  • Schedules do not permit participation in classes or home practice (including planning to move out of town)
  • Paralysis
  • Unable to walk two city blocks
  • Unable to get up and down from floor
  • Lack of transportation
  • Any planned surgery during the upcoming study period

CONDITIONS/CIRCUMSTANCES THAT MIGHT CONFOUND TREATMENT EFFECTS OR INTERPRETATION OF DATA

  • Pregnant or nursing women as determined by patient self-report
  • Use of psychotropic medication
  • Consumption of more than three alcoholic beverages per day
  • Smoking more than 10 cigarettes per day
  • Recent substance abuse

CONDITION WOULD MAKE IT DIFFICULT TO PROVIDE FULLY INFORMED CONSENT

  • Dementia
  • Long or short-term memory loss
  • Unable to read or speak English
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Yoga

    Yoga group

    Behavioral: Yoga Intervention

Interventions

  • BehavioralYoga Intervention

    Three yoga classes per week for 8 weeks.

    Also known as: Yoga, Ashtanga

06

What researchers measure

Primary outcomes

  1. Intraocular Pressure (IOP)

    Baseline IOP measures will be obtained at two visits prior to the intervention. At each weekly visit, we will obtain two series of IOP measures about one hour apart, similar to the sequence that will be used during the weekly yoga intervention, to estimate trends over an 8-week intervention period. Post-intervention IOP will be measured at a single session one week after the yoga intervention has ended, and at a follow-up visit one month after the yoga intervention. Subjects will be masked to the IOP results until they have completed the study.

    Time frame: Change in IOP from mean baseline at 8-weeks (end of yoga intervention period)

Secondary outcomes

  1. Body Mass Index (BMI) (i.e. weight and height)

    Weight and height will be taken at baseline and Post-intervention.

    Time frame: Week 0 and week 8

  2. Blood pressure

    Systemic blood pressure (using a digital monitor with an automated cuff) and pulse rate will be measured at baseline, at the beginning and end of each yoga class, and the two post-intervention visits.

    Time frame: once a week for a total period of 11 weeks; then one additional measure 1 month later

  3. Respiratory Rate (RR)

    Respiratory rate will be measured twice for each participant to reduce within-session variability. It will be determined by counting the number of inhalations with a stethoscope for 30 seconds at rest and multiplying by two at baseline and post-intervention.

    Time frame: Week 0 and Week 8

  4. Pittsburgh Sleep Quality Index (PSQI)

    The 19-item PSQI questionnaire will be used to gauge sleep quality over the past month. It includes both qualitative and quantitative aspects of sleep, and evaluates seven subscale dimensions of sleep quality. Measured at baseline (week 0) and immediately after the 8-week intervention.

    Time frame: Week 0 and Week 8

  5. Perceived Stress Scale (PSS)

    In order to subjectively assess the degree to which respondents have appraised situations in their life to be stressful on a given day, we will administer the 14 item PSS.

    Time frame: Week 0 and Week 8

  6. Beck Anxiety Index (BAI)

    The 21 item BAI will be used to measure the severity of an individual's anxiety over the past month.

    Time frame: Week 0 and Week 8

  7. Beck Depression Index (BDI)

    We will use the BDI to provide a measure of severity and type of depression.

    Time frame: Week 0 and Week 8

  8. Positive and Negative Affect Schedule (PANAS)

    The PANAS questionnaire consists of 10 positive affect items, which reflect one's level of pleasurable engagement with the environment, and 10 negative affect items, which are a general factor of subjective distress.

    Time frame: Week 0 and Week 8

  9. Vision Test/Ocular Disease Catastrophizing Scale

    The Catastrophizing Scale includes 20 questions that measure the individual's state and/or trait immediately after vision tests are performed.

    Time frame: Week 0 and Week 8

  10. Philadelphia Mindfulness Scale (PHLMS)

    This 20-item scale assesses two components of mindfulness, acceptance and awareness. Total scores on both subscales range from 20 to 100, higher scores reflect greater mindfulness. The PHLMS will be collected at baseline, during week 4 and post- intervention.

    Time frame: Week 0, Week 4 and Week 8

  11. Exit Survey

    Participants will complete a brief survey regarding their experience with the yoga class. The survey is comprised of open-ended and multiple-choice response items (e.g. treatment expectations).

    Time frame: Week 8

  12. Practice Log

    Participants will be asked to complete a weekly log online to report the activity performed, time allotted to the practice and will be used to evaluate compliance.

    Time frame: once a week for a total period of 8 weeks

07

Study locations

1 site
  • Lions Vision and Research Rehabilitation
    Baltimore, Maryland 21205, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 26, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01446588
Lead sponsor
Johns Hopkins University
Responsible party
Pamela Jeter (Postdoctoral Research Fellow, Johns Hopkins University) — Principal investigator
First posted
Oct 5, 2011
Start date
Jun 2012
Primary completion
Dec 2012
Completion
Dec 2012
Last update
May 26, 2014

Study contacts

Ava Bittner, OD, PhD
principal investigator · Johns Hopkins University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in May 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion